Three years after its initial FDA approval, Roche has made up for an early disadvantage with its blood cancer drug Lunsumio ...

The average 12-month price target for PICC Property & Casualty is HKD20.78306586, with a high estimate of HKD23.95462092 and a low estimate of HKD14.51909242. 18 analysts recommend buying the stock, ...

The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...

As Forbes Advisor's Editorial Director of Growth Projects, Emily looks after driving editorial innovation and audience engagement through new channels. She oversees the vision for audience-generating ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Drazen Zigic / Getty Images A trade line is created on a borrower’s credit report to track ...

The FDA approves a new subcutaneous formulation of amivantamab, enhancing treatment for advanced lung cancer with reduced administration time and improved safety.

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Yarilet Perez is an experienced multimedia journalist and fact-checker with a Master of ...

Research presented December 8 at the American Society of Hematology Conference in Florida, has shown that a new kind of CAR T-cell therapy, which generates CAR T-cells inside the body, could offer a ...

Julia is the associate news editor for Health, where she edits and publishes news articles on trending health and wellness topics. Her work has been featured in The Heights, an independent student ...

Introduction Refractory headache is a common and frequently disabling disorder, affecting 2–12 million patients each year in ...